Cambridge Innovation Capital
Cambridge Innovation Capital10
About
What does Cambridge Innovation Capital do?
Cambridge Innovation Capital is a leading venture investor in the Cambridge ecosystem, focusing on life sciences and deep tech. They provide financial backing and expert guidance to entrepreneurs in knowledge-intensive businesses, leveraging their unique relationship with the University of Cambridge and deep network to identify and support promising start-ups. Their goal is to enable these pioneers to create world-leading companies with financial success and global impact.
Where is Cambridge Innovation Capital headquartered?
Cambridge Innovation Capital is headquartered in Cambridge, United Kingdom.
When was Cambridge Innovation Capital founded?
Cambridge Innovation Capital was founded in 2013.
What industry does Cambridge Innovation Capital operate in?
Cambridge Innovation Capital operates in Deep Tech, Life Sciences, Biotech, AI, Quantum Technologies.
How many employees does Cambridge Innovation Capital have?
Cambridge Innovation Capital has approximately 35 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.